Skip to content

Evaluation of the Effect of the Listening Program (TLP) Music Therapy Protocol on Attentional and Executive Functions and Nervous System Functional Changes in Children with Level 1 Autism Spectrum Disorder

Evaluation of the Effect of the Listening Program (TLP) Music Therapy Protocol on Attentional and Executive Functions and Nervous System Functional Changes in Children with Level 1 Autism Spectrum Disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20260419069096N1
Enrollment
27
Registered
2026-05-24
Start date
2026-06-22
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism. Autism spectrum disorder without disorder of intellectual development and with mild or no impairment of functional language

Interventions

Intervention 1: Intervention group: Participants receive The Listening Program (TLP) music therapy protocol. The intervention consists of listening to acoustically modified classical music through sta

Sponsors

University of social welfare and rehabilitation sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 12 Years

Inclusion criteria

Inclusion criteria: Diagnosis of Autism Spectrum Disorder Level 1 based on DSM-5 criteria by a qualified psychiatrist, and obtaining a score within the range corresponding to Level 1 on the Gilliam Autism Rating Scale, Third Edition (GARS-3). Age range: 8–12 years. Hearing within the normal range based on recent audiometric examination. Written informed consent from parents or legal guardians. No receipt of music therapy or structured auditory training protocols within the past 24 months. Absence of severe neurological disorders or active seizures, as well as the absence of comorbid conditions such as ADHD. No use of attention-stimulating medications at the time of study entry.

Exclusion criteria

Exclusion criteria: Uncontrolled epilepsy or active seizures within the past six months, or occurrence of seizures during the study period. Initiation or change in dosage of medications affecting attention during the study period. Comorbid severe psychiatric disorders or severe intellectual disability, and any unforeseen medical condition as determined by the investigator/attending physician that would interfere with the implementation of the intervention.

Design outcomes

Primary

MeasureTime frame
Attentional Functions. Timepoint: Before the interventionAfter the intervention3 months after the end of the course. Method of measurement: Integrated Visual and Auditory Continuous Performance Test.

Secondary

MeasureTime frame
Executive Functions. Timepoint: Before the interventionAfter the intervention3 months after the end of the course. Method of measurement: Behavior Rating Inventory of Executive Function.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGolnaz Ahmadi

University of social welfare and rehabilitation sciences

ahmadigolnaz98@gmail.com+98 991 223 0823

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026